HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ozen Oz Gul Selected Research

Ozen Oz Gul Research Topics

Disease

3Diabetes Mellitus
03/2019 - 12/2014
2Atherosclerosis
10/2018 - 01/2018
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
04/2024
1Neoplasm Metastasis (Metastasis)
04/2024
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2022
1Dyslipidemias (Dyslipidemia)
01/2022
1COVID-19
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Diabetes Complications
01/2022
1Adrenocortical Carcinoma
09/2020
1Adenoma (Adenomas)
09/2020
1Carcinoma (Carcinomatosis)
09/2020
1Hypercalcemia (Milk Alkali Syndrome)
07/2020
1Hyperparathyroidism
07/2020
1Parathyroid Neoplasms (Parathyroid Neoplasm)
07/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2020
1Insulinoma
01/2020
1Overweight
03/2019
1Weight Loss (Weight Reduction)
03/2019
1Hyperlipidemias (Hyperlipidemia)
03/2019
1Hypoglycemia (Reactive Hypoglycemia)
01/2019
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
10/2018
1Homozygous Familial Hypercholesterolemia
01/2018
1Coronary Disease (Coronary Heart Disease)
01/2018
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2017
1Insulin Resistance
10/2015
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
10/2015
1Morbid Obesity
10/2015
1Body Weight (Weight, Body)
12/2014
1Neoplasms (Cancer)
10/2014
1Type 2 Diabetes Mellitus (MODY)
10/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2009
1Non-alcoholic Fatty Liver Disease
06/2009

Drug/Important Bio-Agent (IBA)

3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2019
1SteroidsIBA
04/2024
1trans-crotonin (CTN)IBA
04/2024
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2022
1CarbohydratesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
09/2020
1DiureticsIBA
07/2020
1DenosumabFDA Link
07/2020
1CalciumIBA
07/2020
1Diphosphonates (Bisphosphonates)IBA
07/2020
1Parathyroid Hormone (Parathormone)IBA
07/2020
1Calcimimetic AgentsIBA
07/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2020
1Sodium-Glucose Transport ProteinsIBA
03/2019
1LipidsIBA
03/2019
1dapagliflozinIBA
03/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1CholesterolIBA
10/2018
1oxidized low density lipoproteinIBA
01/2018
1LDL CholesterolIBA
01/2018
1ResistinIBA
10/2015
1Nicotinamide PhosphoribosyltransferaseIBA
10/2015
1Blood Glucose (Blood Sugar)IBA
12/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2014
1Rosiglitazone (Avandia)FDA Link
10/2009
1Matrix Metalloproteinases (MMPs)IBA
10/2009
1Metformin (Glucophage)FDA LinkGeneric
10/2009
1Monocyte Chemoattractant ProteinsIBA
10/2009
1Receptor for Advanced Glycation End ProductsIBA
06/2009

Therapy/Procedure

3Glycemic Control
03/2019 - 12/2014
2Therapeutics
07/2020 - 03/2019
1Blood Component Removal (Apheresis)
01/2018
1Thyroidectomy
01/2017
1Diabetic Diet
12/2014